Solara Active Pharma Sciences Limited (BOM:541540)
499.60
+19.50 (4.06%)
At close: Feb 13, 2026
BOM:541540 Statistics
Total Valuation
BOM:541540 has a market cap or net worth of INR 24.07 billion. The enterprise value is 30.52 billion.
| Market Cap | 24.07B |
| Enterprise Value | 30.52B |
Important Dates
The last earnings date was Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 48.17M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +110.38% |
| Shares Change (QoQ) | +2.33% |
| Owned by Insiders (%) | 10.02% |
| Owned by Institutions (%) | 24.07% |
| Float | 33.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 15.04 |
| PS Ratio | 1.92 |
| PB Ratio | 1.91 |
| P/TBV Ratio | 2.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -159.68 |
| EV / Sales | 2.43 |
| EV / EBITDA | 17.81 |
| EV / EBIT | 39.35 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 3.77 |
| Debt / FCF | n/a |
| Interest Coverage | 0.85 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 4.08% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 7.07M |
| Profits Per Employee | -107,662 |
| Employee Count | 1,775 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.84% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -0.84% |
| 50-Day Moving Average | 545.24 |
| 200-Day Moving Average | 575.88 |
| Relative Strength Index (RSI) | 43.97 |
| Average Volume (20 Days) | 5,681 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:541540 had revenue of INR 12.55 billion and -191.10 million in losses. Loss per share was -3.52.
| Revenue | 12.55B |
| Gross Profit | 6.15B |
| Operating Income | 775.40M |
| Pretax Income | -191.10M |
| Net Income | -191.10M |
| EBITDA | 1.68B |
| EBIT | 775.40M |
| Loss Per Share | -3.52 |
Balance Sheet
The company has 38.70 million in cash and 6.46 billion in debt, with a net cash position of -6.42 billion.
| Cash & Cash Equivalents | 38.70M |
| Total Debt | 6.46B |
| Net Cash | -6.42B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 12.57B |
| Book Value Per Share | 293.20 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 49.04%, with operating and profit margins of 6.18% and -1.52%.
| Gross Margin | 49.04% |
| Operating Margin | 6.18% |
| Pretax Margin | -1.52% |
| Profit Margin | -1.52% |
| EBITDA Margin | 13.43% |
| EBIT Margin | 6.18% |
| FCF Margin | n/a |
Dividends & Yields
BOM:541540 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -110.38% |
| Shareholder Yield | -110.38% |
| Earnings Yield | -0.79% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |